Search Results

Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion.

• Authors : Phipps, Richard P; Kaufman, Julia; Blumberg, Neil

Subjects: BLOOD platelet transfusion; FEVER; BLOOD cells

• Source: Lancet. 6/23/2001, Vol. 357 Issue 9273, p2023-2024. 2p. 2 Graphs.

Record details

MarketLine Company Profile: Celldex Therapeutics, Inc.

Subjects: *PHARMACEUTICAL industryUNITED StatesCELLDEX Therapeutics Inc. CELLDEX Therapeutics Inc. CELLDEX Therapeutics Inc. CLDX

• Source: Celldex Therapeutics, Inc. MarketLine Company Profile. 1/30/2024, p1-23. 23p.

Record details

Genetics of immunodeficiency disorders.

• Authors : Levy, Arden; Liu, Andrew

Subjects: IMMUNOLOGICAL deficiency syndromes; GENETICS

• Source: Pediatrics. Aug94 Part 2 of 2, Vol. 94 Issue 2, p280. 1/2p.

Record details

The rudimentary phase of personalised medicine: coronary risk scores.

• Authors : Topol, Eric J.; Lauer, Michael S.

Subjects: HEART disease susceptibility; CLINICAL trials; BLOOD platelets

• Source: Lancet. 11/29/2003, Vol. 362 Issue 9398, p1776-1777. 2p. 1 Chart.

Record details

Signalling an end to transplant rejection?

• Authors : Rowe, Paul M.

Subjects: ANTIGENS; COMPLICATIONS from organ transplantation; REACTIVITY (Chemistry)

• Source: Lancet. 11/22/1997, Vol. 350 Issue 9090, p1526. 1p. 1 Diagram.

Record details